Kepa Amillano

Adjuvant Palbociclib for Early Breast Cancer: The PALLAS Trial Results (ABCSG-42/AFT-05/BIG-14-03)

Michael Gnant, Amylou C. Dueck, Sophie Frantal et al. · Journal of Clinical Oncology · 2021 · 231 citations · Full text

Medicine, Oncology, Pharmacology +17

Exogenous FABP4 increases breast cancer cell proliferation and activates the expression of fatty acid transport proteins

Sandra Guaita‐Esteruelas, Alba Bosquet, Paula Saavedra-García et al. · Molecular Carcinogenesis · 2016 · 130 citations

Life Sciences, Biochemistry, Molecular Biology +15

Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial

Marco Colleoni, Weixiu Luo, Per Karlsson et al. · The Lancet Oncology · 2017 · 122 citations

Medicine, Gynecology, Oncology +13

Fulvestrant-Palbociclib vs Letrozole-Palbociclib as Initial Therapy for Endocrine-Sensitive, Hormone Receptor–Positive, <i>ERBB2</i>-Negative Advanced Breast Cancer

Antonio Llombart‐Cussac, José Manuel Pérez-García, Meritxell Bellet et al. · JAMA Oncology · 2021 · 106 citations · Full text

Medicine, Oncology, Pharmacology +16

A phase 2 trial of neoadjuvant metformin in combination with trastuzumab and chemotherapy in women with early HER2-positive breast cancer: the METTEN study

Begoña Martı́n-Castillo, Sònia Pernas, Joan Dorca et al. · Oncotarget · 2018 · 76 citations · Full text

Medicine, Oncology, Pharmacotherapy +17